Get Live Data

Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

  2. News & RNS
  3. Regulatory News
  4. Transactions under Novozymes’ stock buyback program

Transactions under Novozymes’ stock buyback program

9 Apr 2018 10:27



Transactions under Novozymes’ stock buyback program



Transactions under Novozymes’ stock buyback program



Please read the full announcement in the attached PDF


Attachment




2018_12_Stock_Buybackprogram_EN





© 2018 GlobeNewswire, Inc. All rights reserved.




Related Shares

Novonesis B Ord (0Q4U)
408.50 (-3.25 / -0.79%%)
400.20 - 416.80
Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.